Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Keros Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +15 vs. Q3 2023
- Shares held
- 25.7M
- +3.24M (+14.4%) vs. Q3 2023
- Total value
- $1.02B
- +$306.4M (+42.7%) vs. Q3 2023
- New holders
- 27
- 43 more added
- Sold out
- 12
- 32 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 357,500 | $14.2M | 3.82% | −2,900−0.8% | Reduced |
| Deutsche Bank AG | 358,276 | $14.2M | 0.01% | +345,704+2,749.8% | Added |
| Parkman Healthcare Partners LLC | 360,467 | $14.3M | 2.03% | +61,992+20.8% | Added |
| Geode Capital Management, LLC | 510,211 | $20.3M | 0.00% | +24,210+5.0% | Added |
| Millennium Management LLC | 522,128 | $20.8M | 0.02% | +318,071+155.9% | Added |
| Eventide Asset Management, LLC | 580,000 | $23.1M | 0.38% | 00.0% | Unchanged |
| Woodline Partners LP | 583,792 | $23.2M | 0.25% | −134,631−18.7% | Reduced |
| ADAR1 Capital Management, LLC | 688,316 | $27.4M | 12.24% | +688,316 | New |
| Franklin Resources Inc | 699,425 | $27.8M | 0.01% | +226,674+47.9% | Added |
| Citadel Advisors LLC | 760,168 | $30.2M | 0.03% | +355,019+87.6% | Added |
| Candriam Luxembourg S.C.A. | 819,062 | $32.6M | 0.22% | +78,001+10.5% | Added |
| Morgan Stanley | 925,388 | $36.8M | 0.00% | +476,687+106.2% | Added |
| Price T Rowe Associates Inc | 1,041,701 | $41.4M | 0.01% | −225,531−17.8% | Reduced |
| State Street Corp | 1,054,367 | $41.9M | 0.00% | +152,367+16.9% | Added |
| Darwin Global Management, Ltd. | 1,060,427 | $42.2M | 8.28% | +1,060,427 | New |
| Braidwell LP | 1,118,961 | $44.5M | 1.63% | −238,348−17.6% | Reduced |
| OrbiMed Advisors LLC | 1,268,734 | $50.4M | 1.01% | −246,000−16.2% | Reduced |
| Vanguard Group Inc | 1,432,195 | $56.9M | 0.00% | +25,764+1.8% | Added |
| Alkeon Capital Management LLC | 1,498,907 | $59.6M | 0.39% | −177,615−10.6% | Reduced |
| BlackRock Inc. | 2,036,788 | $81.0M | 0.00% | +169,439+9.1% | Added |
| FMR LLC | 3,874,204 | $154.0M | 0.01% | +269,276+7.5% | Added |
| Yiheng Capital Management, L.P. | 0 | $0 | 0.00% | −554,151−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −421,438−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −43,700−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −36,200−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −27,245−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −7,917−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −312−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| CHI Advisors LLC | – | – | – | – | Not filed |